O4‐02‐06: ORAL TREATMENT WITH RD2 REDUCES Aβ OLIGOMER LOAD, ENHANCES COGNITION, DECELERATES NEURODEGENERATION, REVERSES DISEASE PHENOTYPE IN OLD‐AGED TG AD MICE, AND IS SAFE IN HUMANS

Authors: Dieter Willbold, Janine Kutzsche, Sarah Schemmert, Antje Willuweit,

Published: 2019-10-18

DOI: 10.1016/j.jalz.2019.06.4751

Source: Full article


Abstract

No abstract found.